Ceptyr
Bothell
About Ceptyr
Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.5M
- Last round: Series Unknown (Dec 2002)
- Website: ceptyr.com
- Phone: 425-486-4317
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/ceptyr-2166129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.